Appeals court backs Gilead in ruling that threatens overseas prescription drug programs
A federal appeals court ruled Thursday that international versions of Gilead's HIV drug Biktarvy differ materially from FDA-regulated U.S. versions
We haven't written up this one. Quartz has the full story — the link below goes straight to it.